Joachim C Mertens
Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study.
Ludz C, Stirnimann G, Semela D, Mertens J, Kremer A, Filipowicz Sinnreich M, Sokollik C, Bernsmeier C, Bresson-Hadni S, McLin V, Rock N, Braegger C, Posovszky C, Müller P, Cremer M, De Gottardi A, Galante A, Furlano R, Righini-Grunder F, Becker B, Böhm S, Heyland K, Nydegger A, Limoni C, Vergani D, Mieli-Vergani G, Di Bartolomeo C, Cerny A, Terziroli Beretta-Piccoli B. Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study. Swiss Med Wkly 2023; 153:40102.
Aug 31, 2023Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study.
Aug 31, 2023Swiss Med Wkly 2023; 153:40102
Ludz Christine, Stirnimann Guido, Semela David, Mertens Joachim C, Kremer Andreas E, Filipowicz Sinnreich Magdalena, Sokollik Christiane, Bernsmeier Christine, Bresson-Hadni Solange, McLin Valérie, Rock Nathalie, Braegger Christian P, Posovszky Carsten, Müller Pascal, Cremer Matthias, De Gottardi Andrea, Galante Antonio, Furlano Raoul, Righini-Grunder Franziska, Becker Björn, Böhm Stephan, Heyland Klaas, Nydegger Andreas, Limoni Costanzo, Vergani Diego, Mieli-Vergani Giorgina, Di Bartolomeo Claudia, Cerny Andreas, Terziroli Beretta-Piccoli Benedetta
A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease.
Ruiz F, Wyss A, Rossel J, Sulz M, Brand S, Moncsek A, Mertens J, Roth R, Clottu A, Burri E, Juillerat P, Biedermann L, Greuter T, Rogler G, Pot C, Misselwitz B, Swiss IBD Cohort Study Group. A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease. Br J Pharmacol 2021; 178:3157-3175.
Mar 10, 2021A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease.
Mar 10, 2021Br J Pharmacol 2021; 178:3157-3175
Ruiz Florian, Wyss Annika, Rossel Jean-Benoit, Sulz Michael Christian, Brand Stephan, Moncsek Anja, Mertens Joachim C, Roth René, Clottu Aurélie S, Burri Emanuel, Juillerat Pascal, Biedermann Luc, Greuter Thomas, Rogler Gerhard, Pot Caroline, Misselwitz Benjamin, Swiss IBD Cohort Study Group
DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Bachofner J, Mullhaupt B, Terziroli Beretta-Piccoli B, Magenta L, Semela D, Fehr J, Moncsek A, Seifert B, Braun D, Baserga A, Künzler-Heule P, Bergamin I, Kröger A, Valli P, Mertens J. DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI. Liver Int 2016
Sep 28, 2016DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Sep 28, 2016Liver Int 2016
Bachofner Jacqueline A, Mullhaupt Beat, Terziroli Beretta-Piccoli Benedetta, Magenta Lorenzo, Semela David, Fehr Jan, Moncsek Anja, Seifert Burkhardt, Braun Dominique, Baserga Adriana, Künzler-Heule Patrizia, Bergamin Irina, Kröger Arne, Valli Piero V, Mertens Joachim C